Theriva Biologics, Inc. (TOVX) stock
TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.14+0.00 (0.00%)
Close on Nov 17, 2026Market cap $6.42MP/E –Yield –
Theriva Biologics cash
Cash and short-term investments held at the end of each period.
Theriva Biologics's cash was $11.34M at Jun 30, 2026. For fiscal 2025 it was $13.06M, up 11.5% from the year before. Over ten years it grew -4.6% a year on average. The highest annual figure on record is $67.33M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.06M | +11.5% |
| FY2024 | Dec 31, 2024 | $11.71M | -49.7% |
| FY2023 | Dec 31, 2023 | $23.28M | -44.4% |
| FY2022 | Dec 31, 2022 | $41.89M | -37.8% |
| FY2021 | Dec 31, 2021 | $67.33M | +981.2% |
| FY2020 | Dec 31, 2020 | $6.23M | -58.6% |
| FY2019 | Dec 31, 2019 | $15.05M | -48.0% |
| FY2018 | Dec 31, 2018 | $28.92M | +69.0% |
| FY2017 | Dec 31, 2017 | $17.12M | -10.2% |
| FY2016 | Dec 31, 2016 | $19.06M | -8.5% |
| FY2015 | Dec 31, 2015 | $20.82M | +18.8% |
| FY2014 | Dec 31, 2014 | $17.53M | +19.8% |
| FY2013 | Dec 31, 2013 | $14.63M | +46.9% |
| FY2012 | Dec 31, 2012 | $9.95M | +49.1% |
| FY2011 | Dec 31, 2011 | $6.68M | +152.1% |
| FY2010 | Dec 31, 2010 | $2.65M | -2.4% |
| FY2009 | Dec 31, 2009 | $2.72M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.34M | -6.5% |
| Q1 FY2026 | Mar 31, 2026 | $14.43M | +44.1% |
| Q4 FY2025 | Dec 31, 2025 | $13.06M | +11.5% |
| Q3 FY2025 | Sep 30, 2025 | $7.53M | -54.1% |
| Q2 FY2025 | Jun 30, 2025 | $12.12M | -27.0% |
| Q1 FY2025 | Mar 31, 2025 | $10.01M | -45.2% |
| Q4 FY2024 | Dec 31, 2024 | $11.71M | -49.7% |
| Q3 FY2024 | Sep 30, 2024 | $16.41M | -47.3% |
| Q2 FY2024 | Jun 30, 2024 | $16.59M | -51.6% |
| Q1 FY2024 | Mar 31, 2024 | $18.26M | -49.4% |
| Q4 FY2023 | Dec 31, 2023 | $23.28M | -44.4% |
| Q3 FY2023 | Sep 30, 2023 | $31.16M | -38.3% |
| Q2 FY2023 | Jun 30, 2023 | $34.25M | -34.5% |
| Q1 FY2023 | Mar 31, 2023 | $36.08M | -36.4% |
| Q4 FY2022 | Dec 31, 2022 | $41.89M | -37.8% |
| Q3 FY2022 | Sep 30, 2022 | $50.49M | -30.0% |
| Q2 FY2022 | Jun 30, 2022 | $52.27M | -29.6% |
| Q1 FY2022 | Mar 31, 2022 | $56.69M | -26.3% |
| Q4 FY2021 | Dec 31, 2021 | $67.33M | +981.2% |
| Q3 FY2021 | Sep 30, 2021 | $72.14M | +1101.2% |
| Q2 FY2021 | Jun 30, 2021 | $74.29M | +821.8% |
| Q1 FY2021 | Mar 31, 2021 | $76.89M | +662.4% |
| Q4 FY2020 | Dec 31, 2020 | $6.23M | -58.6% |
| Q3 FY2020 | Sep 30, 2020 | $6.01M | -67.8% |
| Q2 FY2020 | Jun 30, 2020 | $8.06M | -62.9% |
| Q1 FY2020 | Mar 31, 2020 | $10.09M | -59.2% |
| Q4 FY2019 | Dec 31, 2019 | $15.05M | -48.0% |
| Q3 FY2019 | Sep 30, 2019 | $18.65M | +95.3% |
| Q2 FY2019 | Jun 30, 2019 | $21.71M | +204.6% |
| Q1 FY2019 | Mar 31, 2019 | $24.69M | +123.7% |
| Q4 FY2018 | Dec 31, 2018 | $28.92M | +69.0% |
| Q3 FY2018 | Sep 30, 2018 | $9.55M | -54.6% |
| Q2 FY2018 | Jun 30, 2018 | $7.13M | -46.7% |
| Q1 FY2018 | Mar 31, 2018 | $11.04M | -18.1% |
| Q4 FY2017 | Dec 31, 2017 | $17.12M | -10.2% |
| Q3 FY2017 | Sep 30, 2017 | $21.05M | +362.7% |
| Q2 FY2017 | Jun 30, 2017 | $13.38M | – |
| Q1 FY2017 | Mar 31, 2017 | $13.47M | – |
| Q4 FY2016 | Dec 31, 2016 | $19.06M | – |
| Q3 FY2016 | Sep 30, 2016 | $4.55M | – |
See a number that looks wrong?